With the ground bro­ken on a Van­cou­ver head­quar­ters, an­ti­body mak­er Ab­Cellera will add man­u­fac­tur­ing space next door

The Cana­di­an gov­ern­ment is look­ing to raise the pro­file of the coun­try’s na­tive biotech in­dus­try, and British Co­lum­bia’s Ab­Cellera is the lat­est com­pa­ny to ben­e­fit …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.